ACROBiosystems
ACROBiosystems is an internationally recognized manufacturer of recombinant proteins committed to supporting cancer immunotherapy. ACRO specializes in mammalian cell-based recombinant protein production and process development. ACRO’s goal is to support professionals from pharmaceutical companies, CRO, and research institutes in the field of immunotherapy by providing high-quality proteins, antibodies, and assay kits. ACRO have multiple offices and branches in North America, Europe, and Asia, spanning over 50 countries.
Core Technologies
●Proprietary HEK293 expression platform with strict animal-free and xeno-free conditions
●In-house developed enzymatic and chemical biotin labeling technique with bioactivity and labeling ratio optimized
Feature Brand
With years of experience, ACRO have established their own brands: MABSol® proteins and assay kits. The MABSol® brand products cover every step of the antibody drug development pipeline: diverse antigens for injection and selection; MABSol® Biotin Labeled Proteins for assay, immuno-capture and quantitative analysis; MABSol® Five-Minute MAB Isotyping Kits for antibody isotyping, purification media and MABSol® Fc Receptors for antibody optimization.
Product Feature Pages
Emerging mutants from SARS-CoV-2 Variants
Targets of TME pathways
Targets for Antibody-Drug Conjugates
MABSol® Biotin Labeled Proteins
Product Catalog and Data
Please contact us for any inquiries, questions, or information requests.
Tokyo Future Style, Inc.
info@tokyofuturestyle.com
TEL：029-851-9222 FAX：029-851-9220
